Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Other Accumulated Expenses for 7 consecutive years, with $2.8 million as the latest value for Q4 2025.
- Quarterly Other Accumulated Expenses fell 21.66% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, down 21.66% year-over-year, with the annual reading at $2.8 million for FY2025, 21.66% down from the prior year.
- Other Accumulated Expenses hit $2.8 million in Q4 2025 for Fulgent Genetics, down from $6.9 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $39.9 million in Q3 2021 to a low of $281000.0 in Q3 2023.
- Historically, Other Accumulated Expenses has averaged $6.6 million across 5 years, with a median of $4.1 million in 2024.
- Biggest five-year swings in Other Accumulated Expenses: plummeted 97.94% in 2023 and later skyrocketed 1345.55% in 2024.
- Year by year, Other Accumulated Expenses stood at $680000.0 in 2021, then skyrocketed by 679.56% to $5.3 million in 2022, then dropped by 20.49% to $4.2 million in 2023, then decreased by 13.78% to $3.6 million in 2024, then decreased by 21.66% to $2.8 million in 2025.
- Business Quant data shows Other Accumulated Expenses for FLGT at $2.8 million in Q4 2025, $6.9 million in Q3 2025, and $5.0 million in Q2 2025.